$1.715
-0.044 (-2.56%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ZNTL por análisis de gráficos similares
Alphio's ZNTL stock price prediction model matches the current Zentalis Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.72 (+0.41%). The 1-week path is $1.66 (-2.85%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Zentalis Pharmaceuticals Inc?
Zentalis Pharmaceuticals Inc is not a good buy right now. The current price is $1.85, which is significantly below its 52-week high of $6.95, indicating a substantial decline. The RSI is at 22.255, suggesting the stock is oversold and may not recover soon. Additionally, the company has reported continuous losses, with a net income of -$42,286,000 in Q2 2026 and a forward P/E of 0, reflecting lack of earnings visibility. The main risk is the recent earnings miss, where the EPS was -$0.59, missing estimates by $0.10, which could further undermine investor confidence.
ZNTL cerró en $1.72 el Thursday, tras bajar -2.56%
Zentalis Pharmaceuticals Inc (ZNTL) last closed at $1.71, losing -2.84%. These facts feed the 1-day and 1-week ZNTL price prediction above.
Factores de la previsión
Los factores de la previsión de Zentalis Pharmaceuticals Inc (ZNTL) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ZNTL, ordenadas por similitud.
Análisis de estacionalidad de ZNTL
Historically the probability of a positive November return for ZNTL is 9.30%. January offers the highest probability of a positive month at 36.07%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ZNTL
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.11 | $1.34 | $1.34 | -21.38% |
| Dec 2026 | $1.37 | $1.53 | $1.76 | -10.29% |
En 2026, se proyecta que Zentalis Pharmaceuticals Inc (ZNTL) oscile entre $1.11 y $1.76.
Previsión mensual de Zentalis Pharmaceuticals Inc para 2026
En Nov de 2026, se proyecta que Zentalis Pharmaceuticals Inc promedie $1.34, con un mínimo de $1.11 y un máximo de $1.34.
En Dec de 2026, se proyecta que Zentalis Pharmaceuticals Inc promedie $1.53, con un mínimo de $1.37 y un máximo de $1.76.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.